JAM3 and type 1 diabetes mellitus: Indeed, upon blockade of JAM-C with a neutralizing anti-JAM-C antibody we detected a tendency for a reduced T1D incidence in RIP-LCMV-NP and a reversion of some diabetic RIP-LCMV-GP mice.